1-Ethyl-3-methylimidazolium nitrate

We are 1-Ethyl-3-methylimidazolium nitrate CAS:143314-14-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-Ethyl-3-methylimidazolium nitrate
Synonyms:1-ethyl-3-methylimidazol-3-ium,nitrate
Molecular Formula: C6H11N3O3
Molecular Weight: 173.08
CAS No.: 143314-14-1
Purity: 99%
 
Technical Information

Appearance: yellow liquid	Purity:
NMR:	null
Solubility:	Insolubility:
Impurity content: （1）Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: 40 ℃	Decomposition temperature:
Conductivity:	Electrochemical window:
Viscosity:	Density: 1.367 g/cm

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
 

Related News: Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.143879-80-5 Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.19346-47-5 From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.4-metil-N3- [4- (3-piridinil) -2-pirimidinil] -1,3-bencendiamina CAS:152460-10-1 Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.